Katherine Morel
0000-0002-7968-4032
University of Adelaide
14 papers found
Refreshing results…
NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
Evidence that Ezh2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer
Targeting RET Kinase in Neuroendocrine Prostate Cancer
DMAPT is an Effective Radioprotector from Long-Term Radiation-Induced Damage to Normal Mouse Tissues In Vivo
The Role of RB in Prostate Cancer Progression
The Combination of Metformin and Valproic Acid Has a Greater Anti-tumoral Effect on Prostate Cancer Growth In Vivo than Either Drug Alone
Chronic low dose ethanol induces an aggressive metastatic phenotype in TRAMP mice, which is counteracted by parthenolide
The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer
Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo
Mp83-08 Combination of Metformin and Sodium Valproate for Prostate Cancer: A Rapid Approach From Bench to Clinical Trial.
A Single Whole-Body Low Dose X-Irradiation Does Not Affect L1, B1 and IAP Repeat Element DNA Methylation Longitudinally
The methylation of DNA repeat elements is sex-dependent and temporally different in response to X radiation in radiosensitive and radioresistant mouse strains
Parthenolide as a selective radiosensitiser in the treatment and prevention of prostate cancer.
Missing publications? Search for publications with a matching author name.